Menu

Founder of amfAR and Champion of AIDS Research Dies

Mathilde Krim devoted her life to researching the disease and fighting the stigma associated with it.

Jan 18, 2018
Jim Daley

TOM ZUBACK

The founding chairman of The Foundation for AIDS Research (amfAR), Mathilde Krim, died Monday (January 15). She was 91.

When the first cases of AIDS were reported in 1981, Krim, then the director of the Interferon Lab at the Sloan-Kettering Institute for Cancer Research, recognized the disease’s potential to begin an epidemic. She founded the AIDS Medical Foundation (AMF), the first private organization dedicated to supporting research into the disease, with physician and AIDS researcher Joseph Sonnabend and colleagues in April 1983. A few years later, AMF merged with the National AIDS Research Foundation to become amfAR.  

“My greatest AIDS hero has died,” Peter Staley, a gay rights activist and veteran of the activist group ACT UP, tweeted on Tuesday. He added that Krim was a “warrior against homophobia & AIDS-related stigma, defender of science & public health, and mother-figure to countless activists.”

Krim received a PhD in biology at the University of Geneva, Switzerland, in 1953. She then moved to Israel, where she worked at the Weizmann Institute of Science until 1959. While there, she was part of the team that discovered a method for prenatally determining a fetus’s sex.

In 1958, she moved to New York to join the research staff at Cornell University Medical School. Soon after, she became a research scientist at the Sloan-Kettering Institute and joined the Mailman School of Public Health at Columbia University as an adjunct professor. In 2000, she was awarded the Presidential Medal of Freedom.

“[Krim] saw that AIDS would demand the intellectual resources of the fields of medicine, basic science and public health,” wrote the late Allan Rosenfield, former dean of the Mailman School and member of amfAR’s Board of Trustees (via amfAR). “And she set out to bring them to amfAR to guide its research grantmaking, overturning many stereotypical notions of gay men in the process.”

Krim is survived by her daughter, two grandchildren, and a sister. 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.